Y9D-10405-76501
3 vaccinations
3 coded responses
10 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 210 / MD
- Registered
- 2021-12-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-28
Dose 1 — Pfizer-BioNTech
-
2021-03-21
Dose 2 — Pfizer-BioNTech
-
2021-12-06
Dose 3 — Moderna
-
2021-12-08
Registered in v-safe
-
2021-12-09
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2021-12-10
Survey response — days 1–6 daily, dose 3MedDRA: Oedema peripheral — Feeling: Fair · Muscle or body aches, Rash, not including the immediate area around the injection siteFree text: Swelling under the armMedDRA releases: 2024-11 · check-in free text available
- 2021-12-15
- 2021-12-20
- 2022-01-03
- 2022-01-12
- 2022-01-19
- 2022-03-07
-
2022-06-07
Survey response — 6 months, dose 3MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Runny nose and congestionMedDRA releases: 2024-11 · check-in free text available
-
2022-06-07
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-06-08
-
2022-12-06
Survey response — 12 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: I got Covid in October 2022MedDRA releases: 2024-11 · check-in free text available
-
2022-12-06
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-12-07
- 2022-12-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-28 | Pfizer-BioNTech | No |
| 2 | 2021-03-21 | Pfizer-BioNTech | No |
| 3 | 2021-12-06 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-06-07 | Unsuccessful | |
| 2022-12-06 | Unsuccessful |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Swelling under the arm
Release 11 — 6 months, dose 3
Symptoms: Runny nose and congestion
Release 12 — 12 months, dose 3
Symptoms: I got Covid in October 2022
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Oedema peripheral | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release